GENERVON BIOPHARMACEUTICALS LLC has a total of 47 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 1997. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FIBREX MEDICAL RES & DEV GMBH, PALINGEN INC and PROMEDIOR INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | United States | 7 | |
#4 | Australia | 6 | |
#5 | Canada | 5 | |
#6 | China | 5 | |
#7 | Hong Kong | 5 | |
#8 | Japan | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Ko Pui-Yuk Dorothy | 27 |
#2 | Chau Raymond Ming Wah | 13 |
#3 | Kindy Mark S | 10 |
#4 | Deshpande Deepa M | 5 |
#5 | Kerr Douglas A | 5 |
#6 | Xue Bob Baoguo | 5 |
#7 | Swindell William | 4 |
#8 | Kindy Mark S Ms | 2 |
#9 | Chau Raymond M W | 2 |
#10 | Swindell William R | 2 |
Publication | Filing date | Title |
---|---|---|
WO2018129421A1 | A promising drug candidate for parkinson's disease | |
WO2018119018A1 | Methods of using gm6 in diagnosing and treating alzheimer's disease | |
WO2016210123A1 | Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease | |
AU2009217266A1 | MNTF peptide compositions and methods of use | |
CN101534648A | Methods of treating neuronal disorders using mntf peptides and analogs thereof | |
CA2626728A1 | Mntf differentiation and growth of stem cells | |
AU2004290086A1 | Motoneuronotrophic factor gene sequences | |
WO2004065410A2 | Mntf peptides and compositions and methods of use | |
US6841531B2 | Methods and use of motoneuronotrophic factors | |
EP0958362A1 | Isolation and use of motoneuronotrophic factors |